CD8A and neoplasm: Furthermore, they cross-present tumor antigens to naïve CD8+ T lymphocytes in the lymph node and prime tumor-specific cytotoxic immune response by these cytotoxic T lymphocytes (CTLs), which is crucial for maintaining successful antitumor immunity.